← Eichor
Study identifier: NCT06603558 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

Condition: Chronic Migraine · Episodic Migraine · Migraine  ·  Sponsor: AbbVie

PhaseN/A
Planned participants3000
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the safety and effectiveness of atogepant for the preventive treatment of migraine in Korean adult patients with chronic migraine or episodic migraine under routine clinical practice. Atogepant is an approved drug for preventive treatment of migraine in adults. Approximately 3000 adult participants who are prescribed atogepant by their doctors will be enrolled in this study in Korea. Participants will receive atogepant oral tablets as prescribed by their physician. Participants will be followed for up to week 12. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Celine Im  ·  +82-10-2230-3629  ·  celine.im@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (36)

On Hospital /ID# 285157Busan, Busan Gwang Yeogsi, South KoreaRecruiting
Ryu Sang Hyo Neurosurgery Clinic /ID# 284804Busan, Busan Gwang Yeogsi, South KoreaRecruiting
Dong-A University Medical Center /ID# 275321Busan, Busan Gwang Yeogsi, South KoreaRecruiting
Chungnam National University Hospital /ID# 284724Daejeon, Daejeon Gwang Yeogsi, South KoreaRecruiting
Chuncheon Sacred Heart Hospital /ID# 275315Gangwon-do, Gang Weondo, South KoreaRecruiting
Chonnam National University Hospital /ID# 275318Gwangju, Gwangju Gwang Yeogsi, South KoreaRecruiting
Korea University Ansan Hospital /ID# 284725Ansan-si, Gyeonggido, South KoreaRecruiting
Inje University - Ilsan Paik Hospital /ID# 280738Goyang, Gyeonggido, South KoreaRecruiting
National Health Insurance Corporation Ilsan Hospital /ID# 285128Goyang-si, Gyeonggido, South KoreaRecruiting
Hallym University Dongtan Sacred Heart Hospital /ID# 273581Hwaseong, Gyeonggido, South KoreaRecruiting
Hallym University Dongtan Sacred Heart Hospital /ID# 280737Hwaseong, Gyeonggido, South KoreaRecruiting
Teunteun Hospital /ID# 284730Hwaseong-si, Gyeonggido, South KoreaRecruiting

+ 24 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06603558